Cart
sales@molnova.com
Eperisone hydrochloride
CAS No. 56839-43-1
Eperisone hydrochloride( —— )
Catalog No. M19817 CAS No. 56839-43-1
Eperisone is a skeletal muscle relaxant and a spasmolytic agent related structurally to Tolperisone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | 140 | In Stock |
|
| 500MG | 236 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEperisone hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionEperisone is a skeletal muscle relaxant and a spasmolytic agent related structurally to Tolperisone.
-
DescriptionEperisone is a skeletal muscle relaxant and a spasmolytic agent related structurally to Tolperisone.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationPeriarthritis of shoulder and back painspastic paralyses
Chemical Information
-
CAS Number56839-43-1
-
Formula Weight295.85
-
Molecular FormulaC17H26ClNO
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL
-
SMILESCl.CCc1ccc(cc1)C(=O)C(C)CN1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mihara K et al. Intestinal first-pass metabolism of eperisone in the rat. Pharm Res. 2001 Aug;18(8):1131-7.
molnova catalog
related products
-
7-Ethoxycoumarin
7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
-
Boc-Lys(Ac)-AMC
Commendamide (N-acyl-3-hydroxypalmitoyl-glycine) is a newly discovered GPCR G2A/GPR132 agonist (EC50=11.8 μM) that isolated from Bacteroides vulgatus.
-
Kobusin
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and peroxynitrite scavenging potential.
